Lv1
30 积分 2022-12-01 加入
A Phase 3, Randomized, Controlled Trial of Resmetirom in NASH with Liver Fibrosis
18小时前
已完结
Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial
3天前
已完结
Akero Therapeutics Reports Preliminary Topline Results Showing Statistically Significant Reversall of Compensated Cirrhosis (F4) Due to MASH-by Both Completer and ITT Analyses-at Week 96 ir Phase 2b SYMMETRY Study
3天前
求助中
Wnt/beta‐catenin signaling and its modulators in nonalcoholic fatty liver diseases
21天前
已完结
Safety and efficacy of GLP-1/FGF21 dual agonist HEC88473 in MASLD and T2DM: A randomized, double-blind, placebo-controlled study
21天前
已完结
NAFLD and NASH: etiology, targets and emerging therapies
1个月前
已完结
YAP Alleviates Pulmonary Fibrosis Through Promoting Alveolar Regeneration via Modulating the Stemness of Alveolar Type 2 Cells
1个月前
已完结
Sustained amphiregulin expression in intermediate alveolar stem cells drives progressive fibrosis
1个月前
已完结
Pulmonary fibrosis: from pathogenesis to clinical decision-making
1个月前
已完结
A bacterium-like particle vaccine displaying protective feline herpesvirus 1 antigens can induce an immune response in mice and cats
5个月前
已完结
皖公网安备34019202002308
